Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 164 participants.

Also called NCT01275092

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 164 participants (enrolled count) (from the registry)
Sponsor
Siemens Healthineers Endovascular Robotics, Inc. (from the registry)
Registry
  • NCT NCT01275092
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Colombia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01275092. Allocation not applicable; no masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2011-12 (actual). Results posted on 2013-08-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)
Acronym
PRECISE
Condition
Coronary Disease
Condition
Myocardial Ischemia
Condition
Heart Diseases
Condition
Cardiovascular Diseases
Condition
Arteriosclerosis
Condition
Arterial Occlusive Diseases
Condition
Vascular Diseases
Intervention (Device)
CorPath robotic-assisted PCI (percutaneous coronary intervention)
Lead sponsor
Siemens Healthineers Endovascular Robotics, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01275092
Content hash
5f454759fad2da923ef2c86ee02635bdeb98ffff5c662663befdd418946aebe9